↓ Skip to main content

Laquinimod for multiple sclerosis.

Overview of attention for article published in Cochrane database of systematic reviews, August 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

blogs
1 blog
twitter
5 tweeters

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
84 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Laquinimod for multiple sclerosis.
Published in
Cochrane database of systematic reviews, August 2013
DOI 10.1002/14651858.cd010475.pub2
Pubmed ID
Authors

He D, Han K, Gao X, Dong S, Chu L, Feng Z, Wu S, He, Dian, Han, Kai, Gao, Xiangdong, Dong, Shuai, Chu, Lan, Feng, ZhanHui, Wu, Shan

Abstract

Multiple sclerosis (MS) is a chronic immune-mediated, inflammatory, demyelinating, neurodegenerative disorder of the central nervous system, and it causes major socioeconomic burden for the individual patient and for society. An inflammatory pathology occurs during the early relapsing stage of MS and a neurodegenerative pathology dominates the later progressive stage of the disease. Not all MS patients respond adequately to currently available disease-modifying drugs (DMDs). Alternative MS treatments with new modes of action are required to expand the current options for disease-modifying therapies (DMTs) and to aim for freedom from relapses, inflammatory lesions, disability progression and neurodegeneration. Laquinimod has dual properties of immunomodulation and neuroprotection and is a potentially promising new oral DMD in the treatment of relapsing MS.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
South Africa 1 1%
Brazil 1 1%
Unknown 81 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 26%
Student > Ph. D. Student 15 18%
Researcher 10 12%
Student > Bachelor 9 11%
Student > Doctoral Student 4 5%
Other 14 17%
Unknown 10 12%
Readers by discipline Count As %
Medicine and Dentistry 38 45%
Nursing and Health Professions 9 11%
Social Sciences 6 7%
Psychology 4 5%
Biochemistry, Genetics and Molecular Biology 4 5%
Other 6 7%
Unknown 17 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 November 2017.
All research outputs
#1,335,457
of 12,211,623 outputs
Outputs from Cochrane database of systematic reviews
#3,102
of 8,269 outputs
Outputs of similar age
#18,034
of 149,162 outputs
Outputs of similar age from Cochrane database of systematic reviews
#40
of 114 outputs
Altmetric has tracked 12,211,623 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,269 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.6. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 149,162 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 114 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.